The frequency of mucosal-associated invariant T cells is selectively increased in dermatitis herpetiformis

Australasian Journal of Dermatology

Volumn 58, Issue 3, 2017, Pages 200-204

  Li, Jane ^a   Reantragoon, Rangsima ^a,b   Kostenko, Lyudmila ^a   Corbett, Alexandra Jane ^a   Varigos, George ^c   Carbone, Francis Robert ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

dermatitis herpetiformis; immunology; T cells

Indexed keywords

CD103 ANTIGEN; CD161 ANTIGEN; LYMPHOCYTE ANTIGEN; ALPHA E INTEGRINS; ALPHA INTEGRIN; CTAGE1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; T LYMPHOCYTE ANTIGEN;

ALOPECIA AREATA; ARTICLE; BLOOD ANALYSIS; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; MUCOSAL-ASSOCIATED INVARIANT T CELL; PATHOGENESIS; PROTEIN EXPRESSION; PSORIASIS; SKIN; SKIN BIOPSY; STAINING; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM;

ALOPECIA AREATA; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; DERMATITIS HERPETIFORMIS; HUMANS; INTEGRIN ALPHA CHAINS; LYMPHOCYTE COUNT; MEMBRANE GLYCOPROTEINS; MUCOSAL-ASSOCIATED INVARIANT T CELLS; PSORIASIS; SKIN;

EID: 84960172441     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/ajd.12456     Document Type: Article

References (15)

1. Martin E, Treiner E, Duban L et al. Stepwise development of MAIT cells in mouse and human. PLoS Biol. 2009; 7: e54.
2. Kjer-Nielsen L, Patel O, Corbett AJ et al. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 2012; 491: 717–23.
3. Ussher JE, Klenerman P, Willberg CB. Mucosal-associated invariant T-cells: new players in anti-bacterial immunity. Front Immunol. 2014; 5: 450.
4. Young MH, U'Ren L, Huang S et al. MAIT cell recognition of MR1 on bacterially infected and uninfected cells. PLoS One 2013; 8: e53789.
5. Teunissen MB, Yeremenko NG, Baeten DL et al. The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J. Invest. Dermatol. 2014; 134: 2898–907.
6. Agace WW, Higgins JM, Sadasivan B et al. T-lymphocyte-epithelial-cell interactions: integrin alpha(E)(CD103)beta(7), LEEP-CAM and chemokines. Curr. Opin. Cell Biol. 2000; 12: 563–8.
7. Clark RA, Chong B, Mirchandani N et al. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 2006; 176: 4431–9.
8. Reantragoon R, Corbett AJ, Sakala IG et al. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells. J. Exp. Med. 2013; 210: 2305–20.
9. Corbett AJ, Eckle SB, Birkinshaw RW et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 2014; 509: 361–5.
10. Dusseaux M, Martin E, Serriari N et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 2011; 117: 1250–9.
11. Johnston A, Gudjonsson JE. Psoriasis and the MAITing game: a role for IL-17A+ invariant TCR CD8+ T cells in psoriasis? J. Invest. Dermatol. 2014; 134: 2864–6.
12. Borghi-Scoazec G, Merle P, Scoazec JY et al. Onset of dermatitis herpetiformis after treatment by interferon and ribavirin for chronic hepatitis C. J. Hepatol. 2004; 40: 871–2.
13. Zebrowska A, Wagrowska-Danilewicz M, Danilewicz M et al. IL-17 expression in dermatitis herpetiformis and bullous pemphigoid. Mediators Inflamm. 2013; 2013: 967–987: doi.10.1155/2013/967987.
14. Amerio P, Verdolini R, Giangiacomi M et al. Expression of eotaxin, interleukin 13 and tumour necrosis factor-alpha in dermatitis herpetiformis. Br. J. Dermatol. 2000; 143: 974–8.
15. Dunne MR, Elliott L, Hussey S et al. Persistent changes in circulating and intestinal gammadelta T cell subsets, invariant natural killer T cells and mucosal-associated invariant T cells in children and adults with coeliac disease. PLoS One 2013; 8: e76008.